Tirz 5mg (Tirzepatide/Mounjaro)
Tirzepatide is a synthetic peptide that simultaneously activates GLP‑1 and GIP receptors, helping to moderate blood glucose and curb appetite for weight management.
Request COA opens a chat with Jenny — she'll send the most recent Certificate of Analysis (purity, sterility, identity) so you can verify before ordering.
Tirzepatide belongs to the class of peptide agonists targeting incretin receptors, primarily GLP‑1 and GIP. By binding these receptors it modestly enhances insulin responsiveness and signals satiety pathways, which can lead to reduced caloric intake and modest changes in body composition. Researchers and clinicians explore it as a tool for supporting metabolic health, weight reduction, and glucose regulation. When handling, keep the product refrigerated and protect it from light, and follow aseptic techniques to maintain stability.
Dosage Protocol: • Starting Dose: 2.5mg injected subcutaneously once weekly for the first 4 weeks. • Standard Dosage: 5mg weekly after the initial adjustment period. • Advanced Use: Dosages may be increased incrementally up to 10mg weekly, based on individual response. • Tips: Administer at the same time each week, rotate injection sites, and store the solution properly in a refrigerator.
Verbatim reference from public source. Aevum does not prescribe; outline is shown for informational and educational purposes only. Always consult a qualified practitioner.
This component is sold in 5mg vials. Add it to your stack to compute total vials needed for your run length and dosing schedule.
The information shown here is for informational and educational purposes only. It is not medical advice, diagnosis, or treatment. Aevum does not sell, source, or administer any component. Always consult a qualified practitioner before acting on any protocol.